Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
iBio: Risky, But Early Stage Pipeline Potentially Offers Long-Term Reward
Seeking Alpha
Sat, 02/12/11 - 12:53 pm
iBio
biosimilars
Datamonitor: Diabetes growth won't stop CV, metabolic market slide
Fierce Pharma
Thu, 02/10/11 - 10:37 am
diabetes
cardiovascular disease
generics
biosimilars
Generics Companies Weigh In on Biological Drugs
WSJ
Mon, 01/31/11 - 08:00 am
biosimilars
Biosimilars: Empty Threats?
InVivo
Tue, 01/18/11 - 11:58 am
biosimilars
Novartis
Sandoz
Roche
Rituxan
Biosimilars vitalizing Korea's drug industry
The Korea Times, Korea
Sun, 01/16/11 - 11:44 am
biosimilars
Korea
Merck Enlists Parexel to Support Development of Promising Biosimilars
Seeking Alpha
Sun, 01/16/11 - 11:36 am
Merck
Parexel
biosimilars
Merck and Parexel Form Strategic Alliance
Bloomberg
Wed, 01/12/11 - 12:07 pm
Merck
Parexel
biosimilars
Merck BioVentures
Novartis plans trial of equivalent to Roche drug
Marketwatch
Mon, 01/10/11 - 12:16 pm
Roche
Novartis
biosimilars
Rituxan
Sandoz
rheumatoid arthritis
rituximab
Spectrum Pharma Jumps in With the Big Dogs
Motley Fool
Thu, 01/6/11 - 07:40 am
Spectrum Pharmaceuticals
Roche
biosimilars
Biogen Idec
Rituxan
Regulatory experts see huge challenges on biosimilar rules
Fierce Biotech
Thu, 12/2/10 - 10:20 am
biosimilars
FDA
Europe
Teva Gets Boost From Biosimilars
Seeking Alpha
Tue, 11/23/10 - 09:37 am
Teva Pharmaceuticals
biosimilars
Lonza
small molecule drugs
Amgen proposes key hurdles for biosimilar regs
Fierce Biotech
Tue, 11/2/10 - 11:27 am
Amgen
biosimilars
Lovenox Copycat Takes Market Share From Sanofi
Motley Fool
Sat, 10/23/10 - 10:40 am
Sanofi
Lovenox
biosimilars
blood thinners
Momenta
Sandoz
Biosimilar threat tarnishes Novo's star status
Reuters
Tue, 10/19/10 - 11:07 am
Novo Nordisk
insulin
biosimilars
Biocon
Pfizer
Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Bloomberg
Tue, 10/19/10 - 09:17 am
Pfizer
Biocon
insulin
biosimilars
EMA: Few pharmas expected to tackle biosimilar antibodies
Fierce Biotech
Mon, 10/4/10 - 07:51 pm
biosimilars
EMA
Rituxan
Good News for Hospira
Yahoo/Zacks.com
Mon, 09/27/10 - 12:01 pm
Nivestem
Hospira
biosimilars
Amgen
Biosimilars: This Decade's Most Disruptive Technology
PharmExec
Thu, 09/23/10 - 09:40 am
biosimilars
FDA Schedules Meeting on Biosimilars
TheStreet.com
Mon, 09/20/10 - 12:20 pm
FDA
biosimilars
MedImmune Bets Its Fate on “Biobetters”
PharmExec
Fri, 09/10/10 - 11:21 am
MedImmune
AstraZeneca
biosimilars
Pages
« first
‹ previous
…
34
35
36
37
38
39
40
41
42
next ›
last »